Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Adult Infection Management
  4. Back
  5. Antimicrobial Drug Information
  6. Synergistic Gentamicin for Endocarditis in adults (426)
Please update your RDS mobile app to version 4.7.1

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. When you install the update, you will see that each toolkit has a small QR code icon the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively install the update to install RDS app version 4.7.1 to see this improvement. Installing this update is also strongly recommended to get the full benefits of the new contingency arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits. 

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number.  To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

Synergistic Gentamicin for Endocarditis in adults (426)

ALL patients with suspected or proven infective endocarditis (IE) should be discussed with microbiology or Infectious Diseases (ID) within 72 hours of starting antibiotic therapy AND re-discussed after 2 weeks if continuation of gentamicin is being considered.

Synergistic gentamicin is recommended in the initial empirical treatment of endocarditis and for some particular endocarditis pathogens, in accordance with national guidelines. When treating a patient with IE remember to consider resistance, clinical response, toxicity and suitability for outpatient parenteral antibiotic therapy (OPAT).

Resources

Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 04/09/2023

Next review date: 31/08/2026

Author(s): Ysobel Gourlay.

Version: 4

Author email(s): ysobel.gourlay@ggc.scot.nhs.uk.

Approved By: Antimicrobial Utilisation Committee

Reviewer name(s): Ysobel Gourlay.

Document Id: 426